Monthly Archives: January 2023

Oral octreotide gets green light from European body

Posted on January 20, 2023 by cacsnets

The European Medicines Agency’s Committee for Orphan Medicinal Products has adopted a positive opinion for “orphan designation” for the use of the oral octreotide Mycapssa in the treatment of carcinoid syndrome associated with neuroendocrine tumors. Mycapssa, already approved in the US … Continue reading →

Posted in News & Resources | Tagged , , | Leave a comment